Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,820 | 212 | 67.4% |
| Travel and Lodging | $2,630 | 7 | 30.5% |
| Education | $185.04 | 2 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $3,140 | 36 | $0 (2024) |
| NeoTract Inc. | $1,866 | 13 | $0 (2020) |
| Astellas Pharma US Inc | $921.79 | 67 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $377.24 | 16 | $0 (2024) |
| Coloplast Corp | $275.84 | 3 | $0 (2023) |
| ABBVIE INC. | $262.69 | 14 | $0 (2024) |
| Myovant Sciences Inc. | $249.27 | 12 | $0 (2022) |
| Teleflex LLC | $215.00 | 5 | $0 (2022) |
| TOLMAR Pharmaceuticals, Inc. | $200.74 | 10 | $0 (2022) |
| Dendreon Pharmaceuticals LLC | $193.74 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $857.60 | 35 | Sumitomo Pharma America, Inc. ($227.75) |
| 2023 | $717.51 | 33 | Sumitomo Pharma America, Inc. ($149.49) |
| 2022 | $859.33 | 46 | Astellas Pharma US Inc ($275.59) |
| 2021 | $746.98 | 39 | Astellas Pharma US Inc ($194.58) |
| 2020 | $486.63 | 21 | Boston Scientific Corporation ($168.83) |
| 2019 | $2,185 | 23 | NeoTract Inc. ($1,784) |
| 2018 | $855.22 | 11 | BOSTON SCIENTIFIC CORPORATION ($416.18) |
| 2017 | $1,927 | 13 | BOSTON SCIENTIFIC CORPORATION ($1,875) |
All Payment Transactions
221 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: HORMONE THERAPY | ||||||
| 11/06/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: HORMONE THERAPY | ||||||
| 10/24/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: UROLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/10/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Immunotherapy | ||||||
| 10/08/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: HORMONE THERAPY | ||||||
| 09/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/12/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: HORMONE THERAPY | ||||||
| 09/06/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/08/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: HORMONE THERAPY | ||||||
| 08/02/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: UROTHELIAL CANCER | ||||||
| 07/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/26/2024 | HealthTronics Stone Solutions, LLC | Dornier MedTech (Medical Supply), Dornier MedTech, Dornier MedTech | Food and Beverage | Cash or cash equivalent | $10.65 | General |
| Category: Ureteroscopy | ||||||
| 07/18/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: ONCOLOGY | ||||||
| 07/03/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: HORMONE THERAPY | ||||||
| 06/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/15/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: HORMONE THERAPY | ||||||
| 05/03/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $108.51 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 05/01/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Oncology | ||||||
| 04/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Oncology | ||||||
| 04/16/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: HORMONE THERAPY | ||||||
| 04/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,586 | 4,227 | $1.0M | $235,858 |
| 2022 | 26 | 2,519 | 3,783 | $1.1M | $251,346 |
| 2021 | 22 | 2,071 | 3,283 | $967,184 | $236,600 |
| 2020 | 24 | 1,689 | 2,456 | $676,373 | $114,839 |
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 412 | 610 | $226,000 | $54,518 | 24.1% |
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Office | 2023 | 11 | 53 | $130,592 | $35,797 | 27.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 29 | 204 | $153,000 | $26,508 | 17.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 279 | 406 | $104,342 | $25,736 | 24.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 75 | 93 | $63,519 | $17,129 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 119 | 119 | $57,414 | $13,993 | 24.4% |
| 52441 | Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | Office | 2023 | 11 | 11 | $39,710 | $10,343 | 26.0% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 14 | 14 | $29,271 | $7,716 | 26.4% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 14 | 15 | $26,635 | $6,207 | 23.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 424 | 678 | $20,823 | $5,172 | 24.8% |
| 51725 | Simple measurement of pressure of urine flow in bladder | Office | 2023 | 25 | 27 | $17,550 | $4,411 | 25.1% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 167 | 229 | $24,045 | $4,112 | 17.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 565 | 1,008 | $25,200 | $3,932 | 15.6% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 16 | 16 | $11,163 | $2,821 | 25.3% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 23 | 23 | $12,391 | $2,252 | 18.2% |
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Facility | 2023 | 12 | 56 | $8,159 | $2,148 | 26.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 170 | 234 | $3,510 | $1,966 | 56.0% |
| 52441 | Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | Facility | 2023 | 12 | 12 | $7,210 | $1,823 | 25.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $7,458 | $1,793 | 24.0% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 14 | 33 | $5,867 | $1,519 | 25.9% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 13 | 16 | $8,390 | $1,485 | 17.7% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 30 | 47 | $4,584 | $1,155 | 25.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $3,945 | $1,120 | 28.4% |
| 51701 | Insertion of temporary bladder tube | Office | 2023 | 23 | 28 | $3,600 | $902.61 | 25.1% |
| 84402 | Testosterone (hormone) level, free | Office | 2023 | 20 | 28 | $980.00 | $698.88 | 71.3% |
About Dr. Cameron Ghaffary, M.D
Dr. Cameron Ghaffary, M.D is a Surgery healthcare provider based in Galveston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2014. The National Provider Identifier (NPI) number assigned to this provider is 1629498159.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cameron Ghaffary, M.D has received a total of $8,635 in payments from pharmaceutical and medical device companies, with $857.60 received in 2024. These payments were reported across 221 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($5,820).
As a Medicare-enrolled provider, Ghaffary has provided services to 8,865 Medicare beneficiaries, totaling 13,749 services with total Medicare billing of $838,644. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.
Practice Information
- Specialty Surgery
- Location Galveston, TX
- Active Since 04/23/2014
- Last Updated 03/09/2016
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1629498159
Products in Payments
- GENERAL - ERECTILE DYSFUNCTION (Device) $1,917
- UROLIFT (Device) $1,608
- AMS (Device) $707.09
- ORGOVYX (Drug) $626.51
- UroLift (Device) $345.17
- XTANDI (Drug) $332.04
- Myrbetriq (Drug) $325.87
- BOTOX (Biological) $276.68
- Porges Coloplast (Device) $255.00
- ELIGARD (Drug) $222.13
- PROVENGE (Drug) $193.74
- XIAFLEX (Biological) $163.77
- JELMYTO (Drug) $161.24
- UroLift System (Device) $126.94
- 16 FR. FLEXIBLE VIDEO CYSTOSCOPE (Device) $110.79
- GENERAL ERECTILE DYSFUNCTION (Device) $98.49
- MYRBETRIQ (Drug) $97.51
- Olympus Stents (Device) $94.26
- GREENLIGHT (Device) $86.97
- BARDIA (Device) $66.46
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Galveston
Dr. Sarah Samreen, M.b.b.s, M.B.B.S
Surgery — Payments: $27,357
Zachary Griffith, M.d, M.D
Surgery — Payments: $15,715
Andre Son, Md, MD
Surgery — Payments: $10,102
Abigail Forbes, M.d, M.D
Surgery — Payments: $6,599
Dr. Shawn Robinson, Md, MD
Surgery — Payments: $4,552
Dr. Brian Oliver, M.d, M.D
Surgery — Payments: $4,101